Rain Therapeutics Inc. (NASDAQ:RAIN) went down by -5.66% from its latest closing price compared to the recent 1-year high of $15.08. The company’s stock price has collected 26.58% of gains in the last five trading sessions.
Is It Worth Investing in Rain Therapeutics Inc. (NASDAQ :RAIN) Right Now?
Opinions of the stock are interesting as 7 analysts out of 7 who provided ratings for Rain Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
RAIN currently public float of 23.44M and currently shorts hold a 1.14% ratio of that float. Today, the average trading volume of RAIN was 60.32K shares.
RAIN’s Market Performance
RAIN stocks went up by 26.58% for the week, with a monthly jump of 47.87% and a quarterly performance of 20.30%, while its annual performance rate touched -45.09%. The volatility ratio for the week stands at 12.86% while the volatility levels for the past 30 days are set at 10.19% for Rain Therapeutics Inc. The simple moving average for the period of the last 20 days is 28.53% for RAIN stocks with a simple moving average of 50.36% for the last 200 days.
Analysts’ Opinion of RAIN
Many brokerage firms have already submitted their reports for RAIN stocks, with H.C. Wainwright repeating the rating for RAIN by listing it as a “Buy.” The predicted price for RAIN in the upcoming period, according to H.C. Wainwright is $10 based on the research report published on September 12th of the current year 2022.
Oppenheimer, on the other hand, stated in their research note that they expect to see RAIN reach a price target of $15. The rating they have provided for RAIN stocks is “Outperform” according to the report published on April 01st, 2022.
Goldman gave a rating of “Neutral” to RAIN, setting the target price at $22 in the report published on September 14th of the previous year.
RAIN Trading at 39.26% from the 50-Day Moving Average
After a stumble in the market that brought RAIN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -46.95% of loss for the given period.
Volatility was left at 10.19%, however, over the last 30 days, the volatility rate increased by 12.86%, as shares surge +41.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +26.98% upper at present.
During the last 5 trading sessions, RAIN rose by +26.58%, which changed the moving average for the period of 200-days by +5.96% in comparison to the 20-day moving average, which settled at $6.34. In addition, Rain Therapeutics Inc. saw -37.89% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at RAIN starting from BERGER FRANKLIN M, who purchase 77,000 shares at the price of $8.27 back on Nov 22. After this action, BERGER FRANKLIN M now owns 1,005,207 shares of Rain Therapeutics Inc., valued at $636,790 using the latest closing price.
BERGER FRANKLIN M, the Director of Rain Therapeutics Inc., purchase 45,000 shares at $7.80 during a trade that took place back on Nov 21, which means that BERGER FRANKLIN M is holding 928,207 shares at $351,000 based on the most recent closing price.
Stock Fundamentals for RAIN
Equity return is now at value -66.90, with -59.20 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 8.96.